{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T18:27:18Z","timestamp":1793212038233,"version":"4.5.0"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,6,7]],"date-time":"2019-06-07T00:00:00Z","timestamp":1559865600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Reproductive Toxicology"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1016\/j.reprotox.2019.05.066","type":"journal-article","created":{"date-parts":[[2019,6,7]],"date-time":"2019-06-07T22:15:06Z","timestamp":1559945706000},"page":"125-139","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":75,"special_numbering":"C","title":["Fetal methotrexate syndrome: A systematic review of case reports"],"prefix":"10.1016","volume":"87","author":[{"given":"Eline A.","family":"Verberne","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma","family":"de Haan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Peter","family":"van Tintelen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dick","family":"Lindhout","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mieke M.","family":"van Haelst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.reprotox.2019.05.066_bib0005","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1016\/S0022-3476(68)80430-5","article-title":"Methotrexate-induced congenital malformations","volume":"72","author":"Milunsky","year":"1968","journal-title":"J. Pediatr."},{"issue":"9","key":"10.1016\/j.reprotox.2019.05.066_bib0010","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S0968-8080(97)90020-3","article-title":"Research Training in Human R. Methotrexate for the termination of early pregnancy: a toxicology review","volume":"5","author":"Undp\/Unfpa\/Who\/World Bank Special Programme of Research D","year":"1997","journal-title":"Reprod. Health Matters"},{"issue":"10","key":"10.1016\/j.reprotox.2019.05.066_bib0015","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0186487","article-title":"First trimester medication abortion practice in the United States and Canada","volume":"12","author":"Jones","year":"2017","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.reprotox.2019.05.066_bib0020","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1002\/bdra.23003","article-title":"Teratogen update: methotrexate. Birth defects research part A","volume":"94","author":"Hyoun","year":"2012","journal-title":"Clin. Mol. Teratol."},{"issue":"12","key":"10.1016\/j.reprotox.2019.05.066_bib0025","first-page":"2360","article-title":"Low dose methotrexate in the first trimester of pregnancy: results of a French collaborative study","volume":"31","author":"Lewden","year":"2004","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.reprotox.2019.05.066_bib0030","series-title":"EUROCAT Guide 1.4: Instruction for the Registration of Congenital Anomalies","author":"EUROCAT","year":"2013"},{"issue":"1","key":"10.1016\/j.reprotox.2019.05.066_bib0035","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1002\/ajmg.a.20503","article-title":"Methotrexate\/misoprostol embryopathy: report of four cases resulting from failed medical abortion","volume":"123a","author":"Adam","year":"2003","journal-title":"Am. J. Med. Genet. A"},{"issue":"11","key":"10.1016\/j.reprotox.2019.05.066_bib0040","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1016\/S1701-2163(16)30422-4","article-title":"Methotrexate embryopathy in a surviving intrauterine fetus after presumed diagnosis of ectopic pregnancy: case report","volume":"26","author":"Addar","year":"2004","journal-title":"J. Obstet. Gynaecol. Can."},{"issue":"2","key":"10.1016\/j.reprotox.2019.05.066_bib0045","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1002\/(SICI)1096-9926(199802)57:2<51::AID-TERA2>3.0.CO;2-9","article-title":"Adult and two children with fetal methotrexate syndrome","volume":"57","author":"Bawle","year":"1998","journal-title":"Teratology"},{"issue":"5","key":"10.1016\/j.reprotox.2019.05.066_bib0050","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1002\/art.1780400527","article-title":"Multiple congenital anomalies associated with weekly low-dose methotrexate treatment of the mother","volume":"40","author":"Buckley","year":"1997","journal-title":"Arthritis Rheum."},{"issue":"7","key":"10.1016\/j.reprotox.2019.05.066_bib0055","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1002\/ajmg.a.33496","article-title":"Holoprosencephaly and genitourinary anomalies in fetal methotrexate syndrome","volume":"152a","author":"Corona-Rivera","year":"2010","journal-title":"Am. J. Med. Genet. A"},{"issue":"1","key":"10.1016\/j.reprotox.2019.05.066_bib0060","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1002\/(SICI)1096-9926(199907)60:1<10::AID-TERA5>3.0.CO;2-H","article-title":"Developmental delay in fetal aminopterin\/methotrexate syndrome","volume":"60","author":"Del Campo","year":"1999","journal-title":"Teratology"},{"issue":"4","key":"10.1016\/j.reprotox.2019.05.066_bib0065","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1002\/bdra.20116","article-title":"A de novo, apparently balanced reciprocal translocation in a child with developmental delay whose mother was being treated with low-dose methotrexate at the time of conception. Birth defects research Part A","volume":"73","author":"Delatycki","year":"2005","journal-title":"Clin. Mol. Teratol."},{"issue":"6","key":"10.1016\/j.reprotox.2019.05.066_bib0070","first-page":"286","article-title":"[Effect, on the fetus, of methotrexate (amethopterin) administered to the mother. Presentation of a case]","volume":"33","author":"Diniz","year":"1978","journal-title":"Rev. Hosp. Clin."},{"issue":"5","key":"10.1016\/j.reprotox.2019.05.066_bib0075","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1097\/00001665-200309000-00027","article-title":"Cleft palate and toe malformations in a child with fetal methotrexate exposure","volume":"14","author":"Granzow","year":"2003","journal-title":"J. Craniofac. Surg."},{"issue":"6","key":"10.1016\/j.reprotox.2019.05.066_bib0080","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1002\/pd.334","article-title":"In utero first trimester exposure to low-dose methotrexate with increased fetal nuchal translucency and associated malformations","volume":"22","author":"Krahenmann","year":"2002","journal-title":"Prenat. Diagn."},{"issue":"4","key":"10.1016\/j.reprotox.2019.05.066_bib0085","doi-asserted-by":"crossref","first-page":"146","DOI":"10.3844\/ajptsp.2007.146.147","article-title":"Anomalies in a fetus exposed to methotrexate in the first trimester","volume":"2","author":"Lorenz","year":"2007","journal-title":"Am. J. Pharmacol. Toxicol."},{"key":"10.1016\/j.reprotox.2019.05.066_bib0090","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.reprotox.2013.10.005","article-title":"Methotrexate embryopathy after exposure to low weekly doses in early pregnancy","volume":"43","author":"Martin","year":"2014","journal-title":"Reprod. Toxicol."},{"issue":"3","key":"10.1016\/j.reprotox.2019.05.066_bib0095","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.jcjo.2011.05.001","article-title":"The Peters anomaly following antenatal exposure to methotrexate and hydroxychloroquine","volume":"46","author":"Mulholland","year":"2011","journal-title":"Can. J. Ophthalmol."},{"issue":"4","key":"10.1016\/j.reprotox.2019.05.066_bib0100","first-page":"599","article-title":"Multiple anomalies in a fetus exposed to low-dose methotrexate in the first trimester","volume":"99","author":"Nguyen","year":"2002","journal-title":"Obstet. Gynecol."},{"issue":"6","key":"10.1016\/j.reprotox.2019.05.066_bib0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2011.07.002","article-title":"Outcome following high-dose methotrexate in pregnancies misdiagnosed as ectopic","volume":"205","author":"Nurmohamed","year":"2011","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"4","key":"10.1016\/j.reprotox.2019.05.066_bib0110","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1007\/s00246-011-9913-z","article-title":"Congenital cardiac defects: a possible association of aminopterin syndrome and in utero methotrexate exposure?","volume":"32","author":"Piggott","year":"2011","journal-title":"Pediatr. Cardiol."},{"issue":"3","key":"10.1016\/j.reprotox.2019.05.066_bib0115","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.fertnstert.2011.06.014","article-title":"Importance of timing of gestational exposure to methotrexate for its teratogenic effects when used in setting of misdiagnosis of ectopic pregnancy","volume":"96","author":"Poggi","year":"2011","journal-title":"Fertil. Steril."},{"issue":"21","key":"10.1016\/j.reprotox.2019.05.066_bib0120","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.5694\/j.1326-5377.1971.tb92712.x","article-title":"Methotrexate-induced congenital malformations","volume":"2","author":"Powell","year":"1971","journal-title":"Med. J. Aust."},{"issue":"2","key":"10.1016\/j.reprotox.2019.05.066_bib0125","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1002\/bdra.20199","article-title":"A case of methotrexate embryopathy with holoprosencephaly, expanding the phenotype. Birth defects research Part A","volume":"76","author":"Seidahmed","year":"2006","journal-title":"Clin. Mol. Teratol."},{"issue":"1","key":"10.1016\/j.reprotox.2019.05.066_bib0130","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/S0377-1237(09)80068-3","article-title":"Fetal anomalies in rheumatoid arthritis patient exposed to low dose methotrexate","volume":"65","author":"Singh","year":"2009","journal-title":"Med. J. Armed Forces India"},{"issue":"3","key":"10.1016\/j.reprotox.2019.05.066_bib0135","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.ijgo.2007.05.039","article-title":"Methotrexate embryopathy after therapy for misdiagnosed ectopic pregnancy","volume":"99","author":"Usta","year":"2007","journal-title":"Int. J. Gynaecol. Obstet."},{"issue":"2","key":"10.1016\/j.reprotox.2019.05.066_bib0140","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1097\/SCS.0000000000002423","article-title":"Craniosynostosis following fetal methotrexate exposure","volume":"27","author":"Zarella","year":"2016","journal-title":"J. Craniofac. Surg."},{"issue":"5","key":"10.1016\/j.reprotox.2019.05.066_bib0145","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1002\/art.38368","article-title":"Pregnancy outcome after methotrexate treatment for rheumatic disease prior to or during early pregnancy: a prospective multicenter cohort study","volume":"66","author":"Weber-Schoendorfer","year":"2014","journal-title":"Arthritis & rheumatology (Hoboken, NJ)"},{"issue":"2","key":"10.1016\/j.reprotox.2019.05.066_bib0150","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1001\/jama.2016.19193","article-title":"Folic acid supplementation for the prevention of neural tube defects: an updated evidence report and systematic review for the US preventive services task force","volume":"317","author":"Viswanathan","year":"2017","journal-title":"Jama"},{"issue":"1","key":"10.1016\/j.reprotox.2019.05.066_bib0155","first-page":"1","article-title":"Updated estimates of neural tube defects prevented by mandatory folic Acid fortification - United States, 1995-2011","volume":"64","author":"Williams","year":"2015","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"issue":"10","key":"10.1016\/j.reprotox.2019.05.066_bib0160","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1093\/aje\/153.10.961","article-title":"Neural tube defects in relation to use of folic acid antagonists during pregnancy","volume":"153","author":"Hernandez-Diaz","year":"2001","journal-title":"Am. J. Epidemiol."},{"issue":"6","key":"10.1016\/j.reprotox.2019.05.066_bib0165","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1002\/tera.1420470605","article-title":"Clinical teratology counseling and consultation case report: low dose methotrexate exposure in the early weeks of pregnancy","volume":"47","author":"Feldkamp","year":"1993","journal-title":"Teratology"},{"issue":"3","key":"10.1016\/j.reprotox.2019.05.066_bib0170","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.hoc.2012.02.002","article-title":"The antifolates","volume":"26","author":"Visentin","year":"2012","journal-title":"Hematol. Oncol. Clin. North Am."},{"issue":"6","key":"10.1016\/j.reprotox.2019.05.066_bib0175","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/0002-9343(90)90522-F","article-title":"Outcome of first-trimester exposure to low-dose methotrexate in eight patients with rheumatic disease","volume":"88","author":"Kozlowski","year":"1990","journal-title":"Am. J. Med."},{"issue":"8","key":"10.1016\/j.reprotox.2019.05.066_bib0180","first-page":"1872","article-title":"Low dose weekly methotrexate in early pregnancy. A case series and review of the literature","volume":"27","author":"Ostensen","year":"2000","journal-title":"J. Rheumatol."}],"container-title":["Reproductive Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S089062381930036X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S089062381930036X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T13:51:46Z","timestamp":1760190706000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S089062381930036X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8]]},"references-count":36,"alternative-id":["S089062381930036X"],"URL":"https:\/\/doi.org\/10.1016\/j.reprotox.2019.05.066","relation":{},"ISSN":["0890-6238"],"issn-type":[{"value":"0890-6238","type":"print"}],"subject":[],"published":{"date-parts":[[2019,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Fetal methotrexate syndrome: A systematic review of case reports","name":"articletitle","label":"Article Title"},{"value":"Reproductive Toxicology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.reprotox.2019.05.066","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}